- Total revenue rose to $5.14B vs $2.99B YoY, with Medical Loss Ratio improving to 84.0% from 88.5%.
- Swung to net income of $167.3M (diluted EPS $0.49) compared to a loss of $137.5M in Q3 2025.
- Raised FY 2026 guidance, projecting higher revenue of $19.0B–$19.3B and operating income of $850M–$950M.
Signal #143433 · SEC 8-K
$OSCR SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $OSCR filing catalyst
Why did $OSCR trigger an AI stock catalyst alert?
$OSCR triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +7.5/10). Headline: Oscar Health Q3 2026 Reports Profitable Turnaround and Raises Full-Year Guidance. Key points: - Total revenue rose to $5.14B vs $2.99B YoY, with Medical Loss Ratio improving to 84.0% from 88.5%. - Swung to net income of $167.3M (diluted EPS $0.49) compared to a loss of $137.5M in Q3 2025. - Raised FY 2026 guidance, projecting higher revenue of $19.0B–$19.3B and operating income of $850M–$950M.
How did $OSCR stock react after the SEC filing?
After the SEC 8-K for $OSCR, observed market reaction: T0 price $35.19. Past moves do not guarantee future results.
Where can I get real-time $OSCR SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $OSCR via Telegram and the VIP Web Terminal from €10/month.